Healiva is a patient centric Biotech company and we are using a multi-pronged approach to address patient needs by combining enzyme technology, medical devices, and cell therapy to deliver end-to-end personalised solutions for chronic wounds.

Products, services, technology

Healiva 001: cutting-edge autologous cell graft, a differentiated epidermal layer derived from adult progenitor cells. Healiva 002: allogenic cell spray, active through growth factors stimulation, targeted for patients with VLCs. Healiva 003: our enzymatic debrider, a painless, easy-to-use.

Cooperation possibilities

In-licensing, Out-licensing, Business Development, Distribution

Location

Corso Elvezia 4, 6900 Lugano, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    1-9